ORAL-CONTRACEPTIVE PILLS AND PROLACTIN

被引：2
|
作者：
ZACUR, HA
机构：
来源：
SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY | 1989年 / 7卷 / 03期
关键词：
D O I：
10.1055/s-2007-1021406
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：239 / 245
页数：7
相关论文
共 50 条
  • [21] ELEVATED PROLACTIN LEVELS IN ORAL-CONTRACEPTIVE PILL-RELATED HYPERTENSION
    LEHTOVIRTA, P
    RANTA, T
    SEPPALA, M
    FERTILITY AND STERILITY, 1981, 35 (04) : 403 - 405
  • [22] ORAL-CONTRACEPTIVE AGENTS DO NOT AFFECT SERUM PROLACTIN IN NORMAL WOMEN
    DAVIS, JRE
    SELBY, C
    JEFFCOATE, WJ
    CLINICAL ENDOCRINOLOGY, 1984, 20 (04) : 427 - 434
  • [23] CHOICE OF AN ORAL-CONTRACEPTIVE
    LANGER, A
    DEVANESAN, M
    PELOSI, MA
    APUZZIO, JJ
    FRATTAROLA, M
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1976, 126 (02) : 153 - 157
  • [24] ORAL-CONTRACEPTIVE FOR MEN
    BRIGGS, M
    BRIGGS, M
    NATURE, 1974, 252 (5484) : 585 - 586
  • [25] ORAL-CONTRACEPTIVE AGENTS
    GLASS, RH
    WESTERN JOURNAL OF MEDICINE, 1975, 122 (01): : 66 - 67
  • [26] ORAL-CONTRACEPTIVE HYPERTENSION
    LARAGH, JH
    POSTGRADUATE MEDICINE, 1972, 52 (03) : 98 - &
  • [27] FIBRINOLYTIC-ACTIVITY IN WOMEN ON ORAL-CONTRACEPTIVE PILLS - VARIATION DUE TO HEMOGLOBIN GENOTYPE
    FAMODU, AA
    ERHUNMWUNSE, RU
    ELOM, EU
    ACTA TROPICA, 1992, 52 (2-3) : 135 - 138
  • [28] ORAL-CONTRACEPTIVE HAZARDS
    不详
    PHARMACY INTERNATIONAL, 1980, 1 (03): : 51 - 52
  • [29] DANAZOL AS AN ORAL-CONTRACEPTIVE
    LAUERSEN, NH
    WILSON, KH
    FERTILITY AND STERILITY, 1977, 28 (03) : 289 - 289
  • [30] LEUPROLIDE AND ESTROGEN VERSUS ORAL-CONTRACEPTIVE PILLS FOR THE TREATMENT OF HIRSUTISM - A PROSPECTIVE RANDOMIZED STUDY
    AZZIZ, R
    OCHOA, TM
    BRADLEY, EL
    POTTER, HD
    BOOTS, LR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12): : 3406 - 3411
12345